Is Chimerix Stock a Good Investment?
Chimerix Investment Advice | CMRX |
- Examine Chimerix's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Chimerix's leadership team and their track record. Good management can help Chimerix navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Chimerix's business and its evolving consumer preferences.
- Compare Chimerix's performance and market position to its competitors. Analyze how Chimerix is positioned in terms of product offerings, innovation, and market share.
- Check if Chimerix pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Chimerix's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Chimerix stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Chimerix is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Chimerix Stock
Researching Chimerix's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 46.0% of the company shares are held by institutions such as insurance companies. The book value of Chimerix was currently reported as 1.51. The company recorded a loss per share of 0.94. Chimerix had not issued any dividends in recent years.
To determine if Chimerix is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Chimerix's research are outlined below:
| Chimerix is way too risky over 90 days horizon | |
| Chimerix appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 324 K. Net Loss for the year was (82.09 M) with loss before overhead, payroll, taxes, and interest of (73.39 M). | |
| Chimerix currently holds about 42.79 M in cash with (69.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49. | |
| Latest headline from kalkinemedia.com: Chimerix Share Price Surpasses 200-Day Moving Average Heres the Reason Why |
Chimerix Quarterly Cash And Short Term Investments |
|
Chimerix uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Chimerix. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chimerix's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Chimerix's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Chimerix's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-08-05 | 2021-06-30 | -0.19 | -0.21 | -0.02 | 10 | ||
2020-05-07 | 2020-03-31 | -0.15 | -0.17 | -0.02 | 13 | ||
2024-05-01 | 2024-03-31 | -0.22 | -0.25 | -0.03 | 13 | ||
2023-08-03 | 2023-06-30 | -0.24 | -0.21 | 0.03 | 12 | ||
2022-08-08 | 2022-06-30 | -0.24 | -0.27 | -0.03 | 12 | ||
2024-02-29 | 2023-12-31 | -0.24 | -0.2 | 0.04 | 16 | ||
2023-11-02 | 2023-09-30 | -0.23 | -0.27 | -0.04 | 17 | ||
2022-05-16 | 2022-03-31 | -0.33 | -0.28 | 0.05 | 15 |
Know Chimerix's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Chimerix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chimerix backward and forwards among themselves. Chimerix's institutional investor refers to the entity that pools money to purchase Chimerix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2024-09-30 | 816 K | Acuitas Investments, Llc | 2024-09-30 | 796.4 K | Adage Capital Partners Gp Llc | 2024-09-30 | 600 K | Northern Trust Corp | 2024-09-30 | 585.9 K | Yakira Capital Management, Inc. | 2024-09-30 | 508.4 K | Goldman Sachs Group Inc | 2024-09-30 | 492.4 K | Bank Of New York Mellon Corp | 2024-09-30 | 388.5 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-09-30 | 344.7 K | State Street Corp | 2024-09-30 | 297.8 K | Ra Capital Management, Llc | 2024-09-30 | 8.8 M | Vanguard Group Inc | 2024-09-30 | 4.3 M |
Chimerix's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 370.69 M.Market Cap |
|
Chimerix's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.44) | (0.47) | |
| Return On Capital Employed | (0.55) | (0.58) | |
| Return On Assets | (0.44) | (0.47) | |
| Return On Equity | (0.38) | (0.40) |
Determining Chimerix's profitability involves analyzing its financial statements and using various financial metrics to determine if Chimerix is a good buy. For example, gross profit margin measures Chimerix's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Chimerix's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Chimerix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chimerix. Check Chimerix's Beneish M Score to see the likelihood of Chimerix's management manipulating its earnings.
Evaluate Chimerix's management efficiency
Chimerix has return on total asset (ROA) of (0.3022) % which means that it has lost $0.3022 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4859) %, meaning that it created substantial loss on money invested by shareholders. Chimerix's management efficiency ratios could be used to measure how well Chimerix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.47 in 2025. Return On Capital Employed is likely to drop to -0.58 in 2025. At this time, Chimerix's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 363.5 K in 2025, whereas Total Assets are likely to drop slightly above 197 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.51 | 3.98 | |
| Tangible Book Value Per Share | 2.51 | 3.98 | |
| Enterprise Value Over EBITDA | (0.57) | (0.60) | |
| Price Book Value Ratio | 0.51 | 0.48 | |
| Enterprise Value Multiple | (0.57) | (0.60) | |
| Price Fair Value | 0.51 | 0.48 | |
| Enterprise Value | 67.8 M | 64.4 M |
The strategic initiatives led by Chimerix's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 1.128 |
Basic technical analysis of Chimerix Stock
As of the 7th of February, Chimerix shows the Risk Adjusted Performance of 0.1269, downside deviation of 3.67, and Mean Deviation of 7.37. Chimerix technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Chimerix's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chimerix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chimerix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chimerix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chimerix's Outstanding Corporate Bonds
Chimerix issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chimerix uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chimerix bonds can be classified according to their maturity, which is the date when Chimerix has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Chimerix's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Chimerix's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1269 | |||
| Market Risk Adjusted Performance | (8.62) | |||
| Mean Deviation | 7.37 | |||
| Semi Deviation | 2.14 | |||
| Downside Deviation | 3.67 | |||
| Coefficient Of Variation | 708.21 | |||
| Standard Deviation | 26.94 | |||
| Variance | 725.96 | |||
| Information Ratio | 0.1376 | |||
| Jensen Alpha | 3.83 | |||
| Total Risk Alpha | 0.953 | |||
| Sortino Ratio | 1.01 | |||
| Treynor Ratio | (8.63) | |||
| Maximum Drawdown | 224.12 | |||
| Value At Risk | (4.81) | |||
| Potential Upside | 7.97 | |||
| Downside Variance | 13.48 | |||
| Semi Variance | 4.56 | |||
| Expected Short fall | (9.26) | |||
| Skewness | 7.88 | |||
| Kurtosis | 63.3 |
| Risk Adjusted Performance | 0.1269 | |||
| Market Risk Adjusted Performance | (8.62) | |||
| Mean Deviation | 7.37 | |||
| Semi Deviation | 2.14 | |||
| Downside Deviation | 3.67 | |||
| Coefficient Of Variation | 708.21 | |||
| Standard Deviation | 26.94 | |||
| Variance | 725.96 | |||
| Information Ratio | 0.1376 | |||
| Jensen Alpha | 3.83 | |||
| Total Risk Alpha | 0.953 | |||
| Sortino Ratio | 1.01 | |||
| Treynor Ratio | (8.63) | |||
| Maximum Drawdown | 224.12 | |||
| Value At Risk | (4.81) | |||
| Potential Upside | 7.97 | |||
| Downside Variance | 13.48 | |||
| Semi Variance | 4.56 | |||
| Expected Short fall | (9.26) | |||
| Skewness | 7.88 | |||
| Kurtosis | 63.3 |
Consider Chimerix's intraday indicators
Chimerix intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chimerix stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 89158.62 | |||
| Daily Balance Of Power | 0.7895 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 4.08 | |||
| Day Typical Price | 4.09 | |||
| Price Action Indicator | 0.12 | |||
| Period Momentum Indicator | 0.15 |
Chimerix Corporate Filings
F4 | 31st of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 30th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 26th of April 2024 Other Reports | ViewVerify |
Chimerix Stock media impact
Far too much social signal, news, headlines, and media speculation about Chimerix that are available to investors today. That information is available publicly through Chimerix media outlets and privately through word of mouth or via Chimerix internal channels. However, regardless of the origin, that massive amount of Chimerix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Chimerix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Chimerix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Chimerix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Chimerix alpha.
Chimerix Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Chimerix can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Chimerix Corporate Management
| MD MBA | Chief Officer | Profile | |
| David CPA | Exec Officer | Profile | |
| Joshua Allen | Chief Imipridones | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Pablo MD | Head Affairs | Profile |
Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.